The Long Run with Luke Timmerman

Luke Timmerman

Booking Overview

An interview podcast focused on biotechnology, drug development, and scientific entrepreneurship, it regularly features biotech CEOs and other leaders discussing the development of medicines and therapies for human health. Credible pitches include biotech founders, pharmaceutical executives, translational scientists, and drug-development experts with substantive therapeutic programs or company-building achievements; booking is likely difficult because the show favors senior industry leaders and in-depth conversations.

Metrics

Episodes: 209

Frequency: Every two weeks

Rating: 4.7/5.0

Estimated listeners: 1,000 - 10,000

Listener location: USA

Contact Information

Publicly listed emails

luke@timmermanreport.com

Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.

Host

Luke Timmerman - Luke Timmerman is a biotech journalist and the founder of Timmerman Report, covering the life sciences industry and the development of innovative medicines.

Booking Intelligence

Booking Requirements

high

Typical Credentials:

Biotech or pharmaceutical chief executives, company founders, senior drug developers, and translational science leaders with direct responsibility for advancing therapeutic programs or building life sciences companies.

Required Achievements:

Leading a biotechnology or pharmaceutical company, Advancing novel medicines or therapeutic programs, Founding or scaling a life sciences venture, Developing treatments for significant human diseases

Recent Guest Discussions

Mathai Mammen - Developing Alpha-helical Peptide Molecules Against Hard-to-drug Disease Targets.

Gary Nabel - Developing A Vaccine For Epstein-barr Virus.

Jason Coloma - Using Human Genetics To Develop Small-molecule Drugs For Kidney Diseases.

Lyn Baranowski - Developing Inhalable Medicines For Severe Lung Diseases.

Heather Turner - Developing A Schizophrenia Drug Designed To Improve Blood-brain-barrier Penetration, Dosing Convenience, And Long-term Adherence.

Recent Topics

Science, Biotechnology, Drug Development, Therapeutics, Biotech Startups

Episodes

Here's the recent few episodes on

The Long Run with Luke Timmerman

Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience

October 07, 2026

Arden Patapoutian, professor of neuroscience at Scripps Research and Howard Hughes Medical Institute, on new discoveries in neuroscience related to our sense of touch, pain, and more.

Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders

September 23, 2026

Cameron Turtle, CEO of Waltham, Mass.-based Spyre Therapeutics, on developing long-lasting antibodies for immune disorders.

Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

September 09, 2026

Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.

Similar Podcasts

Here's 5 similar podcasts to

The Long Run with Luke Timmerman

Biotech 2050 Podcast · High booking difficulty · 1,000 - 10,000 listeners

Publicly listed emails

luke@timmermanreport.com

Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.

Get your clients booked on top podcasts

Try us risk free with a FREE 3 days trial.

Start Your Free Trial

Join hundreds of PR teams using Podseeker to pitch and land bookings